Shares of Hims & Hers Health Inc. ($HIMS) have experienced a downward trend, declining in seven of the last eight trading days. The stock has found some support around the $50 to $51 range, with technical indicators showing a bounce off the 21-day moving average. Market participants have noted the potential for the stock to trade down to the high $30s or around $40, reflecting a possible rollover. Options activity includes the sale of $45 put options expiring on June 20, generating a premium of $2 per share, which equates to a 4.4% return in one month with an effective purchase price approximately 15% below the current level. Additionally, there has been notable buying interest in January 2026 $100 call options, with prices between $6.30 and $6.50, suggesting some investors are positioning for a potential rebound or longer-term upside in the stock.